Gene/Cell Therapies: Sponsors Must Plan For Long-Term Safety Follow-Up Even If They Fold

 
• By Sue Sutter
  
Going out of business
FDA is trying to head off lost follow-up due to a sponsor shutting down. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies